WallStreetZenWallStreetZen

How to Buy Dr Reddys Laboratories Stock

Dr Reddys Laboratories Ltd

Dr Reddys Laboratories is a pharmaceutical company located in India, which is part of the Healthcare sector, and is traded under the ticker RDY on the NYSE exchange.

Dr Reddys Laboratories stock last closed at $54.78, up 0.55% from the previous day, and has decreased 2.56% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.43 percentage points. Dr Reddys Laboratories stock is currently +10.47% from its 52-week low of $49.59, and -6.01% from its 52-week high of $58.28.

At the moment, there are 166.43M RDY shares outstanding. The market value of RDY is $9.12B. In the last 24 hours, 233,162 RDY shares were traded.

How to Buy Dr Reddys Laboratories Stock

Not sure how to invest in Dr Reddys Laboratories stock? Here's how.
  1. Choose where to buy Dr Reddys Laboratories stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Dr Reddys Laboratories stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit funds into your brokerage account: Pick your payment method and add your info.
  4. Analyze Dr Reddys Laboratories stock: The Dr Reddys Laboratories ticker symbol is RDY. Is Dr Reddys Laboratories stock a good investment? Should you buy shares of RDY? How do RDY's underlying business fundamentals look? Do top analysts think Dr Reddys Laboratories is a good buy? Why has RDY's stock price moved recently? (Hint: Our stock market research website can help you figure out if RDY is a good stock to buy).
  5. Make your RDY purchase: Decide if you will purchase RDY shares at the current market price or use a limit order to buy RDY stock at a particular price.
  6. Track your investment in RDY: Create a watchlist to watch your investment in Dr Reddys Laboratories shares.

Step 1: Choose where to buy Dr Reddys Laboratories stock

You will need an online brokerage account to access the NYSE market and buy RDY shares.

A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best online stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world financial markets: From Technology to Industrials, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by opening an account with eToro now.

Open eToro Account

Step 2: Open your brokerage account

Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in RDY stock today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
  2. Input your personal details to create your new brokerage account.
  1. Submit your info by hitting the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your brokerage account

Now that you've created your account on stock market app, you need to deposit funds:

Check out the tutorial below for more details transferring money into your brokerage account.

Get started with eToro today

Step 4: Analyze Dr Reddys Laboratories stock

After you have figured out the best place to buy Dr Reddys Laboratories stock, it's absolutely critical to research their stock before you invest, so you truly comprehend the risk and opportunity.

Dr Reddys Laboratories Numbers

RDY Price
$54.78
1w %
-0.62%
1y %
-2.56%
5y %
69.49%
P/E
30.23x
P/B
3.75x
P/S
3.33x
PEG
3.81x
Revenue
$2.73B
Earnings
$300.61M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$9.12B
Next Earnings
May 12, 2023
Next Dividend
N/A

Fundamentals of RDY

WallStreetZen was built to help average investors perform better fundamental analysis quickly.

You can see all of the due diligence checks on RDY's stock page.

How is RDY stock valued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RDY's intrinsic value.

Using relative valuations ratios:

  • RDY could be overvalued based on its P/E ratio of 30.23x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 18.14x
  • RDY could be overvalued based on its P/B ratio of 3.75x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.79x
  • RDY may be overvalued based on its PEG ratio of 3.81x

You can access more valuation analysis on RDY's stock here.

Is RDY a healthy company?

Passed Financial Due Diligence Checks:

  • There are more short-term assets than short-term liabilities on the RDY balance sheet.
  • RDY profit margin has gone up from 9.1% to 11% in the past year.
  • Total RDY debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than long-term liabilities on the RDY balance sheet.
  • RDY earnings of $424.18M is not sufficient to cover its interest payments.
  • RDY's operating cash flow of $453.38M allows it to safely service it's debt of $431.70M.

Failed Financial Due Diligence Checks:

  • RDY has a relatively high debt to equity ratio of 0.54.

Do Wall Street analysts think it's a good time to buy Dr Reddys Laboratories stock

Out of 1 sell side analysts who give forecasts on RDY, the consensus analyst rating on RDY is a Strong Buy

Please note that analyst forecasts are not stock recommendations, nor are they investment advice.

Latest RDY Analyst Forecasts

Balaji Prasad, a bottom 13% analyst from Barclays maintains RDY with a strong buy rating and raises their RDY price target from $66.00 to $67.00, on Oct 31, 2022.

You can dive deeper into what analysts are forecasting on the Dr Reddys Laboratories stock forecast page.

RDY Trading Indicators

SMA10
54.26
SMA20
53.98
SMA50
53.96
SMA100
54.05
SMA200
53.76
MACD
0.16
MACD Signal
0.08
MACD Histogram
0.08
RSI
56.2
Stochastic %K
59.33
Stochastic %D
56.88
StochRSI %K
62.85
StochRSI %D
58.26

RDY Earnings

Last year, RDY earnings were $300.61M. In the last five year, RDY's earnings have gone up by 10.9% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 15.79%.

Last year, RDY revenue was $2.73B. Over the last 5 year, RDY's revenue has grown by 5.35% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 19.51%.

Dive into RDY's earnings and revenue performance here.

Latest Insiders Trades at RDY

Over the last year, executives and large shareholders at RDY have not bought or sold any shares.

Get more info about who owns RDY shares here.

Does RDY stock generate passive income?

Dr Reddys Laboratories pays a dividend of 1.41%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 2.39%. If you owned $1,000 worth of RDY stock, you would have received $14.13 last year.

Dr Reddys Laboratories dividend payments have consistently grown over the past decade and have remained stable.

Dig into more analysis about Dr Reddys Laboratories dividend yield and history here.

RDY Social Trading Data

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Make your RDY purchase

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a specific price, place a limit order.

Hit the Open Trade button and your broker will place your order.

If you want additional info about investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Track your investment in RDY

Now that you own some RDY shares, you'll want to stay up-to-date on your new shares.

Put RDY on a watchlist to get the latest updates about your RDY stock.

RDY Feed

How to Buy Stock in Dr Reddys Laboratories

To reiterate, here are the 6 steps for buying Dr Reddys Laboratories stock:

  1. Choose where to buy Dr Reddys Laboratories stock
  2. Open your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Dr Reddys Laboratories stock
  5. Make your RDY purchase
  6. Track your investment in RDY

If you need a online brokerage, eToro is our recommended venue.

Get Started with eToro Today

If you would like to get the latest news on your new investment in Dr Reddys Laboratories, get started below.

NYSE: RDY
$54.78+0.30 (+0.55%)
Updated Mar 24, 2023
Open eToro Account
NYSE: RDY
$54.78+0.30 (+0.55%)
Updated Mar 24, 2023
Open eToro Account

FAQ

How much does it cost to buy one Dr Reddys Laboratories share?

As of Mar 24, 2023, it costs $54.78 to buy one share of Dr Reddys Laboratories stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.183 shares of RDY.

Get Started with eToro Today

Is now a good time to buy Dr Reddys Laboratories stock?

According to 1 Wall Street analysts who monitor Dr Reddys Laboratories, their consensus recommendation is to buy Dr Reddys Laboratories stock.

What is the best way to buy Dr Reddys Laboratories stock?

One way to place an order for Dr Reddys Laboratories stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.